Restatement and Legal Investigation Put Ducommun (DCO) Under Fresh Scrutiny

The Schall Law Firm’s investigation into Ducommun (DCO), following the company’s restatement of 2024 and 2025 financials tied to stock based compensation expense recognition, has put the stock’s disclosure practices and internal controls under closer investor review.

Despite the restatement news and legal review, Ducommun’s share price has climbed 59.04% year to date to US$153.95, with a 90 day share price return of 22.49% and a 1 year total shareholder return of 106.31%, pointing to strong momentum.

If this kind of move has you looking for other potential ideas in the market, it could be a good moment to scan the 34 power grid technology and infrastructure stocks

With Ducommun posting a strong recent run, trading at US$153.95 and sitting about 6% below the average analyst price target while an intrinsic estimate implies a larger discount, investors now face a key question: is there still a buying opportunity here, or is the market already pricing in future growth?

Most Popular Narrative: 6.1% Undervalued

Compared to Ducommun's last close at $153.95, the most followed narrative pegs fair value at $164, suggesting some remaining upside in the current price.

Ongoing mix shift toward higher margin engineered products and aftermarket (maintained at 23% of revenues, moving toward 25%+), together with value driven pricing and restructuring actions, is increasing gross margins (recorded at 26.6% in Q2), which supports sustained improvements in net margins and earnings.

Want to see what is doing the real heavy lifting in that fair value? The narrative leans on compounding revenue gains, sharply higher margins, and a future earnings multiple that implies investors are willing to pay up for those improvements. Curious which assumptions matter most and how sensitive the story is to them?

Result: Fair Value of $164 (UNDERVALUED)

However, this hinges on commercial aerospace destocking easing as expected and defense budgets holding up, since extended weakness in either area could quickly undercut that fair value story.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Another Angle On Valuation

The fair value narrative leans heavily on future earnings, but today the stock screens as expensive on sales. Ducommun trades on a P/S of 2.8x versus a fair ratio of 1.3x, even though peers in US Aerospace & Defense sit much higher at 5.5x. That gap can point to either valuation risk or room for a rerating. Which side do you think is more likely?

Next Steps

The balance of risks and rewards in this story is clear, so do not wait around for a consensus to form. You can review the 2 key rewards and 1 important warning sign now.

Looking for more investment ideas?

If Ducommun has caught your attention, do not stop here. Broaden your watchlist with other focused ideas that could suit different goals and risk levels.

• Target potential value opportunities by scanning the 47 high quality undervalued stocks that highlight companies combining quality fundamentals with attractive pricing.
• Prioritize resilience and peace of mind by checking the 63 resilient stocks with low risk scores built around stocks with lower risk scores and steadier profiles.
• Hunt for lesser known opportunities by using the screener containing 20 high quality undiscovered gems that spotlight high quality companies investors may be overlooking.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.